Oncimmune awarded Queen’s Award for Enterprise in Innovation 2022

Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has announced that it has been awarded the Queen’s Award for Enterprise 2022 in the innovation category, endorsing Oncimmune as a leading developer of applied immunodiagnostics for the early detection of disease, drug discovery and development.

With over 10 years as a leader in autoantibody-enabled immunodiagnostics, Oncimmune is the leading global immunodiagnostics developer, primarily focused on the fields of immuno-oncology, autoimmune disease and infectious diseases. As a specialist immunology testing business, the Company has a diversified and growing revenue stream from its discovery and development service-based platform, delivering actionable insights into therapies to its pharmaceutical and biotech partners, as well as a portfolio of diagnostic products to detect early-stage cancer.

The Queen’s Award for Enterprise 2022 acknowledges the innovation behind Oncimmune’s immunodiagnostic and discovery technology.  This started with EarlyCDT, a blood test which can help identify cancer on average four years earlier than current standard clinical diagnosis, and continues today through Oncimmune’s ImmunoINSIGHTS platform, which enables life science organisations to optimise drug development and delivery, leading to more effective targeting as well as safer treatments for patients.

The ImmunoINSIGHTS core immune-profiling technology is underpinned by a library of over 8,800 immunogenic proteins, one of the largest of its kind, which helps to identify clinical trial participants and patients in clinically relevant subgroups, enabling the development of targeted, more effective treatments with a lower risk of adverse events.

Regarded as the highest official UK award for British business and now in its 56th year, the Queen’s Award for Enterprise is an annual award which endorses outstanding achievement in innovation. Oncimmune is one of 226 organisations nationally to be recognised with a prestigious Queen’s Award for Enterprise 2022, which is awarded to products or services that have been available on the market and can demonstrate outstanding innovation and commercial success for at least two years.

The award will be formally presented to Dr Adam M Hill, Chief Executive Officer (CEO), of Oncimmune, by His Royal Highness The Prince of Wales on 12 July 2022.

Dr Adam M Hill, CEO of Oncimmune said: “Oncimmune has established a world-leading position in autoantibody-enabled immunodiagnostics, and we are honoured to have our truly innovative approach recognised by the prestigious Queen’s Award for Enterprise 2022. Since our inception, the mission for Oncimmune has been to use our extensive understanding of the immune system to enable us to harness its sophisticated response to disease in order to detect cancer earlier and to support the development of better therapies. We are delighted to be recognised for the progress we have achieved in oncology, other auto-immune and infectious diseases. I would like to thank all our employees for their continued hard work and dedication in helping us to achieve this vision and we look forward to what the future holds for Oncimmune and its technology.”

Click to view all articles for the EPIC: ,
Or click to view the full company profile:
    Share on facebook
    Facebook
    Share on twitter
    Twitter
    Share on linkedin
    LinkedIn

    More articles like this

    Lookers Plc

    Lookers shares are still undervalued says Zeus

    Lookers plc (LON:LOOK) has released an H1 trading update reporting a continuation of strong performance year to date. H1 2022 underlying PBT is expected to be c. £45m and Management anticipate full year PBT will also be ahead

    SysGroup plc

    SysGroup analyst Zeus forecast a 39.0% increase in revenue in FY23

    SysGroup plc (LON:SYS) is an award-winning provider of managed IT services, cyber security, cloud hosting and IT consultancy. The Group offers investors an attractive business model with high recurring revenue and a diversified customer base. SysGroup is competitively

    AFC Energy

    AFC Energy’s long term opportunity remains vast says Zeus

    AFC Energy plc (LON:AFC) has signed an agreement with another leading UK construction/infrastructure player, this time in Kier Group. We believe this further endorses our long term thesis that AFC will play an active role in encouraging the

    Inchcape

    Inchcape performance exceeding expectations says Zeus

    Inchcape plc (LON:INCH) has released another positive trading update, with performance exceeding expectations so far this year. This follows on from a positive Q1 update on 28 April. Through quarterly improvement in Distribution volumes and operating margin, the

    boohoo Plc

    Boohoo Group analyst Zeus sees a strong performance in Q1

    ¨ Q1 financial highlights: Boohoo Group plc (LON:BOO) revenue of £445.7m is -8.3% YOY vs. a strong comp (Q1 FY22 revenue +32.1%), in line with Zeus’s forecast and management’s previously stated guidance. Gross sales growth remained positive +9%

    AssetCo plc

    AssetCo performs better than forecasts says Zeus

    AssetCo plc (LON:ASTO) has just completed its acquisition of River and Mercantile Group “RMG”, which has resulted in an increase in shares in issue from 8.4m to 14.4m. RMG has an “established and well-respected equities team that manages

    Tatton Asset Management Plc

    Tatton Asset Management meeting or beating Zeus forecasts

    Tatton Asset Management plc (LON:TAM) results to March 2022 are in line with its April trading update, confirming profitable growth with high retention. Headlines are: ¨ Assets under management (“AUM”) rose 26.1% to £11.34bn (2021: £8.99bn) £1,277m net

    Castings plc

    Castings Plc outlook underpinned by new platforms says Zeus

    Castings plc (LON:CGS) FY22 results show a marked recovery on the pandemic impacted FY21 numbers with volumes broadly in line with pre-Covid levels, albeit c.5% below FY19 peak. Revenue increased 29.5% to £148.6m (FY21: £114.7m) with adj operating

    OnTheMarket Plc

    OnTheMarket “delivering on expectations” says Zeus

    OnTheMarket plc (LON:OTMP) full year results to January 2022 are in line with the February trading update: ¨ 32% rise in revenue to £30.4m (FY21: £23.0m); ¨ 12% rise in Group adjusted operating profit to £2.7m (FY21: £2.4m);

    DWF Group Plc

    DWF Group is significantly undervalued says Zeus

    DWF Group plc (LON:DWF) has announced it is on track to deliver our FY22 adjusted PBT forecast despite some challenges particularly on utilisation during H2. Lock up days also continue to fall, and we sense increasing confidence in

    No more posts to show